About  Us       R & D        Pipeline          Partnership           Investor Center         News & Events          Careers

Investor Center Partership News & Events2013 Pipeline Research & Development About Us
Press Releases
More Ascletis News
Copyright © 2011 Ascletis Inc. All rights reserved.
Careers News & Events2013
  Home            Contact  

中文

   Home-Ch    Home Contact

Jul 12, 2012 /  Alnylam and Ascletis form a strategic collaboration to develop ALN-VSP, an RNAi therapeutic for the treatment of liver cancers   >>

N07122012

Oct 23, 2012 /  Dr. Jinzi J. Wu invited to speak at the BIO convention in China  >>

N10232012

ascletis

   Home

Mar 14, 2013 /  Dr. Jinzi J. Wu invited to present at the 3rd Annual China Healthcare Investment Conference  >>

N03142013

Apr 15, 2013 /  Roche and Ascletis enter collaboration to advance treatment options for Chinese patients with Hepatitis-C  >>

N04152013

Apr 30, 2013 /  Ascletis gains China market rights from Janssen to a clinical stage HIV protease inhibitor  >>

N04302013

Think Outside the Box

Research & Development
Partnership
Pipeline
Research & Development Partership

Ascletis is a specialty therapeutics company dedicated to discovering

and developing important new treatments for cancer and infectious diseases.

Pipeline
HIV in China

Status and Treatment Trends of HCV

HCV IN CHINA

HCV

Danoprevir